ATT-11T

N/A

Report date: 2024/05/15 12:01:01

Base Information

Drug NameATT-11T
Drug Alias NameNGC-IrinotecanNext Generation IrinotecanATT-11TPCS-11TPCS11T
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAposense Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProcessa Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsLung NeoplasmsOvarian Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A